Science and Research

T cells of patients with systemic sclerosis or Sjögren's disease display an aberrant metabolic state and memory phenotype in blood and lungs

OBJECTIVES: Systemic sclerosis (SSc) and Sjögren's disease (SjD) are characterized by systemic inflammation. Although for both entities lymphocyte involvement is reported, the contribution of T cell responses to lung manifestation of SSc and SjD remains elusive. Therefore, we aimed for systematically investigating T cell responses in blood and lungs of patients with SSc or with SjD. METHODS: For deep T cell characterization, blood and bronchoalveolar lavages (BALs) from patients with SSc (n = 38) or SjD (n = 36), and healthy controls (HC) (n = 34) were analyzed by spectral flow cytometry. RESULTS: Recirculating blood T cells of patients with SSc showed a significantly increased CD4+ terminally differentiated effector memory (TEMRA) compartment (p= 0.0171) and impaired mitochondrial fitness. In patients with SjD, blood CD8+ T cells were overall reduced and showed an increased expression of CD25 on memory subsets. CD8+ T cells in BAL of patients with SSc- or SjD-associated interstitial lung disease (ILD) expressed significant levels of CD69 and PD1, displaying an exhausted phenotype. In addition, conventional dendritic cells type 2 are highly activated and express increased levels of HLA-DR in BALs of patients with ILD. CONCLUSION: In patients with SSc-ILD and SjD-ILD, a disturbed T cell memory differentiation combined with an exhausted phenotype and reduced metabolic fitness point towards sustained T cell receptor engagement and chronic stimulation. Thus, the retrieved data indicate a significant involvement of T cells in the disease pathology of SSc- and SjD-associated ILD.

  • Ehlers, C.
  • Biermann, H.
  • Thiele, T.
  • Schupp, J. C.
  • Villa, M.
  • Jänke, C.
  • Risser, L. M.
  • Witte, T.
  • Kalinke, U.
  • Seeliger, B.
  • Graalmann, T.

Keywords

  • Sjögren’s disease
  • Systemic sclerosis
  • T cell exhaustion
  • T cells
  • dendritic cells type 2
  • immunomodulation
  • interstitial lung disease
  • mitochondrial fitness
  • systemic autoimmune rheumatic disease
  • terminally differentiated effector memory
Publication details
DOI: 10.1093/rheumatology/keaf198
Journal: Rheumatology (Oxford)
Work Type: Original
Location: BREATH
Disease Area: DPLD
Partner / Member: MHH
Access-Number: 40244816


chevron-down